Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pramlintide combination therapy

Next Previous
X
Search
Drug Profile

Pramlintide combination therapy

Alternative Names: Pramlintide + metreleptin; pramlintide + phentermine; pramlintide + PYY3-36; pramlintide + sibutramine; pramlintide/phentermine; pramlintide/PYY3-36; pramlintide/sibutramine

Latest Information Update: 28 Dec 2012

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Amylin Pharmaceuticals
  • Class Adipokines; Anorectics; Cyclobutanes; Macromolecular substances; Neuropeptides; Proteins
  • Mechanism of Action Adrenergic receptor antagonists; Dopamine uptake inhibitors; Islet amyloid polypeptide stimulants; Leptin receptor agonists; Neuropeptide Y2 receptor agonists; Neurotransmitter stimulants; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Obesity

Most Recent Events

  • 25 Dec 2012 Amylin Pharmaceuticals and Takeda terminate their agreement for this programme
  • 24 Feb 2010 Discontinued - Phase-II for Obesity in USA (Subcutaneous)
  • 24 Feb 2010 Discontinued - Phase-II for Obesity in USA (Injection/PO combination)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top